Clinical Efficacy Of Mongolian Medicine Garigewurile In The Treatment Of SA Disease

Objective: 1.To study the clinical experience of the prescription of the mongolian medicine Garigewurile in the recovery of SA disease(ischemic cerebrovascular disease).2.To observe the effect of Garigewurile on the blood lipids(TC,TG,LDL-C,HDL-C)and homocysteine(Hcy).Methods: Sixty patients aged 40-75 years old who met the diagnostic criteria for convalescence of SA disease(ischemic cerebrovascular disease)were randomly divided into treatment group and control group with 30 cases in each group.treatment group: conventional therapy+take orally Garigewurile,15 pills / times,Warm water service after meals once in the morning and once in the evening.control group: conventional treatment.course of treatment: 14 days.After treatment,NIHSS and m RS score data and test data were evaluated.SPSS22.0 software was used to process the data..Results:1.Curative effect analysis:1.1 NIHSS score:There were differences in NIHSS score between the treatment group and the control group before and after treatment(P < 0.05).The NIHSS score in the treatment group was 33% in the effective group,13% in the marked group,27% in the control group and 10% in the marked group.There was no significant difference between the treatment group and the control group(P > 0.05).1.2 m RS score:there was no significant difference between the treatment group and the control group(P > 0.05).Therefore,the therapeutic effect of the treatment group is better than that of the control group.2.Observation index:The results of comparison before and after treatment in the same group showed:There was statistical significance between TG and LDL-C in treatment group(P < 0.05).Comparing the treatment group with the control group,the results showed that:There were differences between TG and LDL-C(P < 0.05).TC,HDL-C and Hcy had no difference(P > 0.05).Therefore,the treatment group can reduce TG and LDL-C.Conclusion: The curative effect of the treatment group in the convalescent stage of SA disease(ischemic cerebrovascular disease)is better than that of the control group,and it can reduce TG and LDL-C.Therefore,this study demonstrates that Garigewurile can reduce the risk factors of ischemic cerebrovascular disease,such as TG and LDL-C,while treating SA disease.